Leo Sachs

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Leo Sachs, 1955

Leo Sachs (Hebrew: ליאו זקס; born 14 October 1924) is a German-born Israeli molecular biologist and cancer researcher. Born in Leipzig,[1] he Emigrated to England in 1933, and to Israel in 1952. There he joined the Weizmann Institute of Science, where he founded the Department of Genetics.

Contents

Awards and honours [edit]

  • In 1965, He was elected Member of the European Molecular Biology Organisation;
  • In 1972, Sachs was awarded the Israel Prize, for natural sciences[2]
  • In 1975 He was elected Member, Israel Academy of Sciences and Humanities;
  • In 1977 Sachs was awarded the Rothschild Prize in the Biological Sciences;
  • In 1980, he was awarded the Wolf Prize in Medicine,[3] becaming the first Israeli scientist to win the Wolf Prize; for his "contributions to knowledge of the function and dysfunction of the body cells through [his] studies on ... the elucidation of mechanisms governing the control and differentiation of normal and cancer cells".
  • In 1983 Sachs was awarded the Bristol-Myers Award for Distinguished Achievement in Cancer Research, New York;
  • In 1985 He was elected Doctor Honoris Causa, Bordeaux University, France;
  • In 1986 Sachs was awarded The Royal Society Wellcome Foundation Prize, London;
  • In 1989 Sachs was awarded Alfred P. Sloan Prize, General Motors Cancer Research Foundation, New York;
  • In 1995, he was also elected as a Foreign Associate to the U.S. National Academy of Sciences (NAS).
  • In 1996, Sachs received the Ot Hanagid (Medal of the Governor) award, presented annually by Jerusalem's Shaare Zedek Medical Center, for his pioneering work in cancer research. The presentation noted that "He discovered and identified a group of proteins among them colony-stimulating factors and some interleukins that control the viability and growth of blood stem cells and their development into different types of mature blood cells." It noted further that his "research in the 1950s on the use of amniotic fluid to diagnose a fetus s genetic properties has formed the basis for today's prenatal diagnosis of human diseases."[4]
  • In 1997 he was elected a Fellow of the Royal Society [5]
  • In 1998, he was elected Foreign Member, Academia Europaea;
  • In 1999, he was elected Member Honorary Fellow, University of Wales, Bangor;
  • In 2000, he was elected Ham-Wasserman Lecture, American Society of Hematology, San Francisco;
  • In 2001, he was awarded Honorary Life Membership Award, International Cytokine Society;
  • In 2002, he was awarded Emet Prize for Life Sciences, Medicine and Genetics

See also [edit]

References [edit]

External links [edit]